Content by The Scientist

By mapping molecules in cells and tissues, scientists can gain novel insights into various biological processes, such as fetal development and Alzheimer’s disease.

Fasting activates cellular and molecular mechanisms that support cardiovascular wellness.

Mathew Easterday from Dovetail Genomics highlights how combined sequence and structure analysis reveals genome architecture’s role in disease.

Driven by personal setbacks, Nuclera’s founders built a solution to one of biology’s toughest bottlenecks.

A company developing microfluidics and machine learning automation for advanced cellular analysis is one of the 2025 Top Innovations contest winners in the Biotechnology category.

Aaron Gajadhar from Seer talks about a new platform that brings unprecedented speed and depth to plasma proteome analysis.

A dedicated service enables fast and reliable production of bispecific antibodies across a wide range of formats and complexities.

Recognized in the Startup category of the 2025 Top Innovations contest, Countable PCR enables precise counting of DNA and RNA molecules without estimation.

Researchers found inspiration for recent breakthroughs in cancer therapy from unexpected things, such as vitamin precursors, sound, and the menstrual cycle.

Xavier Godron, co-founder and chief technology officer at DNA Script, shares how enzymatic DNA synthesis prioritizes rapid, on-demand access to exceptional quality DNA that supports medical innovation.

Jay Hartenbach from Diakonos Oncology discusses a personalized immunotherapy that primes dendritic cells to launch effective attacks against glioblastoma.

The Lenti-X™ T-Cell Transduction Sponge is honored in the Lab Research Tools category of the 2025 Top Innovations contest.

Hernan Bazan from South Rampart Pharma discusses a new compound that could transform pain relief by sidestepping the drawbacks of opioids and acetaminophen.

Cindy Lawley from Olink shares how an integrated proteogenomic approach using robust population study data is advancing precision medicine.

A company developing Spiroligomers™, a new type of synthetic therapeutic molecules, secures a winning spot in the 2025 Top Innovations contest Emerging Startup category.